Revista portuguesa de cirurgia cardio-toracica e vascular : orgao oficial da Sociedade Portuguesa de Cirurgia Cardio-Toracica e Vascular · 2017
Ross Surgery: Our Experience.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Rodrigues Carolina, Cerejo Rui
Аннотация
INTRODUCTION: At Santa Marta Hospital, Ross Surgery was performed for the first time in 1999. Seventeen years later, it is mandatory to evaluate the mid and long-term results of our experience, as well as prospect the future of this procedure.
METHODS: Between March 1999 and June 2016, 23 Ross procedures were performed at our institution. We did a retrospective analysis of the patient's data, results of the surgery, complications, freedom from reoperation and mortality.
RESULTS: The majority (36,4%) of the patients had aortic stenosis, 22,7% had aortic regurgitation and 27,3% had aortic stenosis and regurgitation. Sub-valvular stenosis was present in 13,6% of patients. The mean follow-up is 12 years. Eighty percent (n=16) of the survivors are in class I of NYHA, with the remaining 20% (n=4) in class II. In our series, 81% of the patients are free from reoperation. The overall cumulative mortality was 9%. There was no operative mortality.
CONCLUSION: Ross surgery has specific indications and in this group of patients the advantages are undeniable and the results, according to our series are positive and encouraging.
METHODS: Between March 1999 and June 2016, 23 Ross procedures were performed at our institution. We did a retrospective analysis of the patient's data, results of the surgery, complications, freedom from reoperation and mortality.
RESULTS: The majority (36,4%) of the patients had aortic stenosis, 22,7% had aortic regurgitation and 27,3% had aortic stenosis and regurgitation. Sub-valvular stenosis was present in 13,6% of patients. The mean follow-up is 12 years. Eighty percent (n=16) of the survivors are in class I of NYHA, with the remaining 20% (n=4) in class II. In our series, 81% of the patients are free from reoperation. The overall cumulative mortality was 9%. There was no operative mortality.
CONCLUSION: Ross surgery has specific indications and in this group of patients the advantages are undeniable and the results, according to our series are positive and encouraging.